CLC bio and J. Craig Venter Institute extend site license

January 14, 2013 |

In Denmark, CLC bio announced that the J. Craig Venter Institute has extended their site license agreement with CLC bio through 2017. JCVI has been utilizing CLC bio’s enterprise platform since 2009 and currently uses it on more than 30 research grants, including their work as part of the Human Microbiome Project. ”The complexity and diversity of our research projects necessitates unique tools to analyze these increasingly large data sets. In our pursuit of excellence we always test and employ the best available tools for our research projects. As such we’re happy to announce the extension of our site license with CLC bio through 2017,” stated Karen Nelson, Ph.D., President, JCVI.

More on the story.

Print Friendly, PDF & Email

Tags:

Category: Dashboard

Thank you for visting the Digest.